After Tom Price reached for the ejector seat two weeks ago after a scandal involving private jet use, Donald Trump has been looking for a new Secretary of Health and Human Services (HHS).
FDA commissioner Scott Gottlieb is continuing his plans to streamline and accelerate the regulators' practices, but now plans to close down at least one glaring loophole in the Orphan Drug
The FDA has rejected Amgen and UCB’s Evenity (romosozumab) osteoporosis drug after a late-stage trial unexpectedly highlighted a potential cardiac safety risk.